Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease

被引:35
|
作者
Falzarano, G
Krenger, W
Snyder, KM
Delmonte, J
Karandikar, M
Ferrara, JLM
机构
[1] DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA
[2] CHILDRENS HOSP, BOSTON, MA USA
[3] HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA
关键词
D O I
10.1182/blood.V87.7.2853.bloodjournal8772853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is associated with impaired B-cell responses. We investigated the mechanism of impaired proliferation of B cells in response to the mitogen lipopolysaccharide (LPS) by analyzing the production of tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO), both of which have independently been described as important effector mechanisms in the pathogenesis of acute GVHD. A threefold decrease of mature surface Ig-positive (sIg(+)) B cells was observed in GVHD spleens isolated 2 weeks after transplant. However, proliferation of these cells in response to LPS was suppressed by more than 35-fold. Activated GVHD splenocytes secreted large amounts of TNF-alpha and NO in culture, Neutralization of TNF-alpha with anti-TNF-alpha antibody (Ab) both abrogated NO production and restored LPS-induced proliferation of B cells to levels found in non-GVHD control mice. The specific inhibition of NO synthesis with L(G)-monomethyl-arginine (NNMA) restored splenocyte responses but did not significantly reduce TNF-alpha levels, showing that TNF-alpha per se did not cause immunosuppression. These data show that, during GVHD, induction of the MO pathway is an important mechanism that mediates B-cell hyporesponsiveness to LPS and that this pathway is induced by TNF-alpha. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2853 / 2860
页数:8
相关论文
共 50 条
  • [21] Mechanisms of regulatory T cell-mediated suppression of alloreactivity in the context of acute graft-versus-host disease
    Lupp, C.
    Bopp, T.
    Schmitt, E.
    Schild, H.
    Radsak, M.
    ONKOLOGIE, 2010, 33 : 265 - 265
  • [22] Suppression of P53 Pathway is an Important Factor Inducing Acute Graft-versus-Host Disease Through T Cell Activation Based on Bioinformatics Analysis
    Wang, Shiyu
    Qin, Wei
    Cheng, Tingting
    Zeng, Cong
    Chen, Xu
    Xu, Yajing
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 4093 - 4104
  • [23] IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation
    Xiaoran Wu
    Yi Tan
    Qiao Xing
    Shengdian Wang
    Protein & Cell, 2013, 4 (11) : 863 - 871
  • [24] IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation
    Wu, Xiaoran
    Tan, Yi
    Xing, Qiao
    Wang, Shengdian
    PROTEIN & CELL, 2013, 4 (11) : 863 - 871
  • [25] Anti-tumor necrosis factor-α for the treatment of steroid-refractory acute graft-versus-host disease
    Nogueira, M. C.
    Azevedo, A. M.
    Pereira, S. C. M.
    Ferreira, J. L.
    Lerner, D.
    Lobo, A. M. G.
    Tavares, R. C. B. S.
    Tabak, D. G.
    Lorenzi, N.
    Renault, I. Z.
    Bouzas, L. F. S.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (12) : 1623 - 1629
  • [26] The role of interferon-γ, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice
    Ellison, CA
    Natuik, SA
    McIntosh, AR
    Scully, SA
    Danilenko, DM
    Gartner, JG
    IMMUNOLOGY, 2003, 109 (03) : 440 - 449
  • [27] TUMOR-NECROSIS-FACTOR-ALPHA ASSOCIATED WITH CHRONIC GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION RECIPIENTS
    FUJII, Y
    KAKU, K
    KANEKO, T
    BONE MARROW TRANSPLANTATION, 1992, 10 (02) : 194 - 195
  • [28] Acute Graft-Versus-Host Disease After Liver Transplant: Novel Use of Etanercept and the Role of Tumor Necrosis Factor α Inhibitors
    Thin, Lena
    MacQuillan, Gerry
    Adams, Leon
    Garas, George
    Seow, Cynthia
    Cannell, Paul
    Augustson, Bradley
    Mitchell, Andrew
    Delriveire, Luc
    Jeffrey, Gary
    LIVER TRANSPLANTATION, 2009, 15 (04) : 421 - 426
  • [29] Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway
    Tamada, K
    Shimozaki, K
    Chapoval, AI
    Zhu, GF
    Sica, G
    Flies, D
    Boone, T
    Hsu, HL
    Fu, YX
    Nagata, S
    Ni, J
    Chen, LP
    NATURE MEDICINE, 2000, 6 (03) : 283 - 289
  • [30] Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway
    Tamada K.
    Shimozaki K.
    Chapoval A.I.
    Zhu G.
    Sica G.
    Flies D.
    Boone T.
    Hsu H.
    Fu Y.-X.
    Nagata S.
    Ni J.
    Chen L.
    Nature Medicine, 2000, 6 (3) : 283 - 289